Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect and Safety of Therapy Adding Cilostazol in Acute Ischemic Stroke Due to Large Artery Atherosclerosis: CHANGE Trial

NCT06757764 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06757764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06757764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect and Safety of Therapy Adding Cilostazol in Acute Ischemic Stroke Due to Large Artery Atherosclerosis: CHANGE Trial
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
July 10, 2025
Completion date
March 31, 2028
Enrollment
2,340 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction, stenosis artery